Carindacillin
Carindacillin (Indanyl carbenicillin; CP-15464-2 free base) is an orally active prodrug of Carbenicillin (HY-B0525). Carindacillin undergoes intestinal uptake via a proton gradient-driven carrier-mediated pathway and is rapidly hydrolyzed in vivo to release the bioactive Carbenicillin, which interferes with cell wall synthesis by inhibiting bacterial penicillin-binding proteins. Carindacillin can be used in research related to bacterial infections.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 35531-88-5
- Fòrmula: C26H26N2O6S
- Peso molecular:494.56
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vitro
Carindacillin (CIPC) is actively transported into rat intestinal BBMV primarily via the monocarboxylic acid transport system, with a Km of 0.54 mM, a Ki of 0.59 mM, and an apparent uptake clearance of 499 × 10-3 µl/mg protein per s[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Chemical Information
-
No. CAS 35531-88-5
-
Peso molecular 494.56
-
Fòrmula C26H26N2O6S
-
SMILES
O=C(OC1=CC=C(CCC2)C2=C1)C(C3=CC=CC=C3)C(N[C@H]4[C@]5([H])N(C4=O)[C@H](C(C)(S5)C)C(O)=O)=O
-
Synonyms
Indanyl carbenicillin; CP-15464-2 free base
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Carindacillin
- 35531-88-5
- Indanyl carbenicillin
- CP-15464-2
- Drug Intermediate
- Bacterial
- rat intestinal BBMV
- brush border membrane vesicles
- oligopeptide transporter
- H+-coupled monocarboxylic acid transport system
- Gly-Sar uptake
- carbenicillin
- chronic pyelonephritis
- ceftibuten uptake
- L-lactic acid uptake
- Inhibitor
- inhibitor
- inhibit